Liabilities / Assets
66th percentile
Higher debt load relative to assets than 66% of similar nonprofits.
Oregon Biotechnology Associati
990 • Fiscal year 2013 • EIN 93-1009329
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.24x
Liabilities / Revenue
48th percentile
Higher debt load relative to revenue than 48% of similar nonprofits.
Net Margin
43rd percentile
Higher net margin than 43% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
80th percentile
Faster asset growth than 80% of similar nonprofits.
Revenue Growth
34th percentile
Faster revenue growth than 34% of similar nonprofits.
Balance Sheet
Assets
Up$180,044
Up $29,427 (+20%) from 2012
Net Assets
Up$137,674
Up $9,072 (+7.1%) from 2012
Liabilities
Up$42,370
Up $20,355 (+92%) from 2012
Revenue And Expenses
Revenue
$554,265
No earlier filing loaded for comparison.
Expenses
Down$545,192
Down $63,467 (-10%) from 2012
Net Income
$9,073
No earlier filing loaded for comparison.
Historical Trend
Filing Detail Status
This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2013 to Dec 31, 2013
Mission and Program Overview
Mission
Promote growth and quality of the Bioscience Industry in Oregon through community collaboration and commercialzation
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2013 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $180,044
- Liabilities
- $42,370
- Net assets
- $137,674
- Revenue
- $554,265
- Expenses
- $545,192
- Net income
- $9,073